Author

Martina de Majo, PhD

February 9, 2024

Advancing Modeling for Neurodegeneration in ALS patients

Strategies to model ALS pathology for a faster track to effective therapeutics
February 9, 2024

A new biomarker for ALS?

A known Alzheimer’s Disease biomarker could be a new blood-based biomarker for Amyotrophic Lateral Sclerosis (ALS)

It is time to leave behind the era of

“I’m sorry but we can’t help you.”

Book your visit
Patients & Families
How It WorksFrequently Asked Questions
For Partners
ProvidersPayersGUIDEResearch
Our Services
Alzheimer's DiseaseFrontotemporal DementiaALS & PLSParkinson's DiseaseHuntington's DiseaseMental Health Care
About us
Leadership TeamOur CliniciansCareersCollaborators & SupportersContact
Resources
Our BlogPress Releases
Legal
Privacy PolicyTerms of ServiceNotice of Privacy PracticesConsumer Health Data Privacy PolicyTelehealth Informed ConsentFCOINondiscrimination Notice

This office appreciates the diversity of human beings and does not discriminate based on race, age, religion, ability,  marital status, sexual orientation, sex or gender identity.

Synapticure logo whitePh: +1 708-630-1534
Fax: +1 888-517-8619

2045 W Grand Ave Ste B Chicago, IL 60612

AICPA SOC 2 logo
© Copyright Synapticure. All rights reserved.